A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults (Q35739841)
Jump to navigation
Jump to search
scientific article published on 7 August 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults |
scientific article published on 7 August 2015 |
Statements
1 reference
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults (English)
1 reference
Etienne Karita
1 reference
Omu Anzala
1 reference
Annet Nanvubya
1 reference
Josephine H Cox
1 reference
Juliet Mpendo
1 reference
Gaudensia Mutua
1 reference
Julien Nyombayire
1 reference
Rosine Ingabire
1 reference
Peter Hayes
1 reference
Jakub Kopycinski
1 reference
Len Dally
1 reference
Drew Hannaman
1 reference
Michael A Egan
1 reference
John H Eldridge
1 reference
Kristen Syvertsen
1 reference
Jennifer Lehrman
1 reference
Beth Rasmussen
1 reference
Jill Gilmour
1 reference
Patricia E Fast
1 reference
Claudia Schmidt
1 reference
7 August 2015
1 reference
1 reference
10
1 reference
8
1 reference
e0134287
1 reference
7 August 2015
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference